- News
News
Welcome to the homepage of AIHTA!
AIHTA is an acadmic non-profit institute. At our website we wish to present our research and give support for health care decision-making. Here all of our reports are available for free. For further information please contact the AIHTA team.
In the News section you will find our most recent publications: newsletter, project-reports etc. Previous reports you might find via Research areas, Research projects and Repository.
Project / HTA-methods & steering instruments
Reimbursement decisions for medical procedures in Austria: An analysis of factors – besides clinical evidence – influencing reimbursement decisions for the hospital benefit catalogue 2010-2020
Project leaders: Gregor Goetz
Project team: Gregor Goetz
Duration: September 2020 – November 2020
Language: English (with German summary)
Project / Oncology, Prevention and screening, Health economics
Lung cancer screening in risk groups Systematic review(s) of effectiveness and utility (part 1) Costs and budgetary consequences (part 2)
Project leaders: Claudia Wild (part 1), Ingrid Zechmeister-Koss (part 2)
Project team:
- Thomas Semlitsch (IAVEM) & EUnetHTA partners (IQWIG, potentially others) (part 1)
- Christan Böhler, Sarah Wolf (part 2)
Duration: May 2020 – November 2020
Language: English with German summary
Project / High tech medicine, European collaboration
Minimally invasive surgical procedures for the treatment of benign prostatic hyperplasia (BPH)
Project leaders: Judit Erdös
Project team: Judit Erdös
& EUnetHTA partners (RER, VASPVT, SNHTA, Azienda Zero)
Duration: May 2020 – January 2021
Language: English with German summary
Project / Prevention and screening, Health economics
Molecular genetic diagnostics as a triage mechanism in cardiology using the example of familial hypercholesterolemia: Organisational and ethical implications (part 1) and economic effects (part 2)
Project team: Melanie Walter, Christoph Strohmaier
Project lead: Melanie Walter (part 1), Christoph Strohmaier (part 2)
Duration: May 2020 – October 2020
Language: English (with German summary)
Project / Psychological & psychiatric interventions
Home treatment in child and adolescent psychiatry: An analysis of effectiveness and integrated care
Project leaders: Sarah Wolf
Project team: Sarah Wolf, Nicole Grössmann
Duration: April 2020 – November 2020
Language: German
Project / High tech medicine
Exoskeletons and functional electrical stimulation (FES) for stroke rehabilitation: a systematic review of effectiveness and safety
Project leaders: Gregor Goetz
Project team: Gregor Goetz, Melanie Walter
Duration: April 2020 – August 2020
Language: English (with German summary)
Newsletter
Note: this content is only available in German.
Inhalt
- Editorial: Elektronische Entscheidungshilfe zur Vermeidung unnötiger Radiologie (MIDAS-Studie)
- Algorithmus-basierte Smartphone-Apps zur Hautkrebsdiagnostik
- Covid-19: Horizon Scanning System
- Brolucizumab zur Therapie von neovaskulärer (feuchter), altersbedingter Makuladegeneration
- Brustkrebs: Biomarker-Tests zur Entscheidung über Chemotherapie
- Termine
- Themen-Vorschau
Announcement
Covid-19: HSS/ Horizon Scanning Living Document (v01 April 2020), Part 1 & Part 2
The establishment of a HSS/ Horizon Scanning System for Covid19 interventions has the intentions of informing health policy makers at an early stage which interventions (vaccinations and drugs) are currently undergoing clinical trials and to monitor them over the next few months in order to support evidence-based purchasing if necessary.
Based on international sources (information gathered by the WHO, preliminary work by other international institutions, publications) first selective searches by means of searches in study registries are carried out for information on clinical studies in humans and the state of research. Thereafter “vignettes” (short descriptions) are developed for those products that are already in an "advanced" stage. Subsequently, the products are monitored with regard to the status of the clinical studies up to approval and finally evaluated for their benefit and harm.
All work steps are conducted in close international (European) cooperation.
Publication: Policy Brief No. 002: http://eprints.aihta.at/1234/
Contact: Claudia Wild
Announcement
Health Services Research in Oncology Part I: End-of-Life Care
Real-world data can provide information on the quality of health care and can inform health care system decisions. The present data analysis was focusing on the health care at the end of life of cancer patients, based on Austrian data (2012 to 2016) from all nine federal states. In the period under review, 283,228 persons with cancer diagnoses were admitted to a publicly financed hospital. Of these, about 29% (80,818) persons died. The proportion of patients who died in the inpatient sector was homogeneous across Austria (~61%) with the exception of Vienna. About 13% of deceased patients were admitted to the hospital two days before their death. With regard to the analysis of special oncological treatments (radiotherapy, chemotherapy and monoclonal antibodies) within 30 days before death, slight variabilities could be observed across the Austrian federal states.
Publication: LBI-HTA Project report No. 127: http://eprints.aihta.at/1233
Contact: Nicole Grössmann
Project / High tech medicine
HSS/ Horizon Scanning for Covid19
Project leaders: Claudia Wild
Project team: All employees of the AIHTA
Coordination (vaccinations): Gregor Götz
Coordination (drugs): Sarah Wolf
Duration: March 2020 – open
Language: English and German
Publication: Policy Brief No. 002: http://eprints.aihta.at/1234/
